Disruptive Digital Screening Innovation Call

 

Versión en español

Desafío DKV

Driving Innovation in Digital Health

DKV Innolab is a team focused on identifying and overcoming challenges in the insurance sector by engaging with the entrepreneurial ecosystem, embracing open innovation, and implementing disruptive technologies within DKV's business. At DKV, we aim to make innovation a core part of our brand and products. Through inspiration and training, we work to make an impact on the business, the ecosystem, and key stakeholders. All of this is driven by two main pillars: Digital Health and Insurtech.

DKV Challenge in Digital Health

The DKV Challenges is DKV Innolab's open innovation program, designed to identify and attract innovative ideas and solutions from the market that address major health-related challenges and add value to the DKV ecosystem.

Annual challenge identification
Imagen: Color fondo
#000000

Innovation call launch
Imagen: Color fondo
#000000

Scouting, certification and winner selection
Imagen: Color fondo
#000000

Collaboration for adoption at DKV
Imagen: Color fondo
#000000

The challenge: Disruptive Digital Screening

Anticipating is key

Many diseases can be prevented if detected early. However, in practice, many people either do not access screening tests or do so too late, when the disease has already progressed.

Early detection not only improves clinical prognosis but also enables intervention before the disease affects quality of life. Early detection means saving time, lowering healthcare costs, and, most importantly, improving health outcomes.

Awareness is not enough

Although society is increasingly aware of the importance of self-care and prevention, this awareness doesn't always translate into action.

The lack of accessible and personalized tools limits the ability to truly anticipate risks.

Technology to expand access to health

The widespread adoption of devices such as smartphones, wearables, and sensors presents a unique opportunity: developing digital solutions that can detect risks and pathologies in a simple, rapid, and scalable way.

Technology is the key to democratizing access to preventive care, making it available to everyone, regardless of geographic or economic barriers.

DKV's vision to address the challenge

At DKV, we are committed to supporting our customers in achieving the best possible health for as long as possible. To that end, we are committed to incorporating innovative technologies through strategic alliances with providers in the digital health ecosystem.

What we are looking for

We are seeking disruptive digital solutions that enable early identification of risks and pathologies within our insured population, with the goal of delivering preventative and personalized interventions.

These solutions must be 100% digital and integrate into DKV’s digital health ecosystem. Below, we outline the priority medical areas and provide some examples for each  (not exclusive).

Ophthalmology

oculista

Early detection of pathologies such as glaucoma, macular degeneration, or diabetic retinopathy.

Respiratory system

aparato respiratorio

Early identification of the risk of developing respiratory diseases.​​

Traumatology

Early detection of fracture risk or other musculoskeletal conditions.​

Apply now

Programme launch

Mentoring programme

This program will provide a detailed view of the Spanish private insurance industry and an understanding of the DKV digital ecosystem in order to integrate and reach end customers. (More information soon)

 

Prize & additional benefits

The prize

DKV Adoption + 10.000 €

The winning solution will enter the process for adoption eligibility as an additional service within one of DKV’s private insurance products. In addition, the winner will be rewarded with 10.000 €.

Prior to adoption and depending on the maturity of the solution, adaptations or prior testing may be required.

Additionally, the winner will have the opportunity to pitch to ERGO health executives, as well as access to a Barcelona Health Hub membership or tickets for the 2026 Health Revolution Congress.

Additional benefits

Eligibility criteria

Previous editions

Cardiovascular health

2024
Imagen: Color fondo
#000000

Healthy aging

2023
Imagen: Color fondo
#000000

Mental health

2022
Imagen: Color fondo
#000000

FAQs & Webinar

 

 

What kind of solutions is DKV looking for in this call?

We are seeking disruptive digital solutions focused on screening and early detection of diseases, especially in ophthalmology, respiratory system, and traumatology. However, applications targeting early detection in other medical fields are also welcome. Solutions must be 100% digital and able to be integrated into DKV’s digital health ecosystem.

What requirements must a solution meet to be eligible?

It must be a digital solution, user-centered (focused on the patient), focused on early screening, compliant with MDR regulations or have a certification plan within 6 months, and be ready for adoption.

What types of solutions are not eligible?

Solutions will not be accepted if they:

  • Require a hospital setting.

  • Are exclusively for healthcare professionals.

  • Are medical devices for clinics or hospitals.

  • Are focused solely on treatment or follow-up.

What benefits does the winning startup receive?

  • Entry into the process for adoption eligibility as an additional service within one of DKV’s private insurance products.

  • A cash prize of €10,000.

  • Visibility, networking, and training.

  • Access to the Spanish insurance ecosystem.

  • The opportunity to pitch to ERGO health executives.

  • Access to a Barcelona Health Hub membership or tickets for the 2026 Health Revolution Congress.

Can foreign startups participate?

Yes, but they must present a plan to adapt their solution to the Spanish market and comply with European and Spanish legal and regulatory requirements.

What level of maturity must the solution have?

A technological maturity level (CIMIT) above 6 is required. The solution must be ready for testing or adoption with possible adaptations. A CIMIT level 7 implies:

  • Regulatory: Application for MDR certification.

  • Business: Purchase attempts by key users / Second round of institutional investment.

  • Clinical: Clinical efficacy studies conducted (e.g., phases 2 and 3), and/or extended clinical safety studies.

  • Technological: Initiation of GMP validation process. You can check the CIMIT here

How are the solutions evaluated?

Criteria include: impact on the insurance business, technological differentiation, user experience, accessibility, and potential for integration into DKV.

DKV Innolab has its own methodology for evaluating digital health solutions. More information is available on the DKV Innolab website

How can I apply for the challenge?

Through the registration form. It is recommended to review all eligibility criteria on the Challenge website before submitting your application.

Do you have a solution to solve this challenge?​

Apply now!

In collaboration with: